GV or gv may refer to:
GV ( IUPAC name: 2-(Dimethylamino)ethyl N,N-dimethylphosphoramidofluoridate) is an organophosphate nerve agent. GV is a part of a new series of nerve agents with properties similar to both the "G-series" and "V-series". It is a potent acetylcholinesterase inhibitor with properties similar to other nerve agents, being a highly poisonous vapour. Treatment for poisoning with GV involves drugs such as atropine, benactyzine, obidoxime, and HI-6.
GV, formerly Google Ventures, is the venture capital investment arm of Alphabet Inc. and provides seed, venture, and growth stage funding to technology companies. The firm operates independently from Google and makes financially driven investment decisions. GV seeks to invest in startup companies in a variety of fields ranging from Internet, software, and hardware to life science, healthcare, artificial intelligence, transportation, cyber security and agriculture.
The group was founded on March 31, 2009, with a $100 million capital commitment. In 2012, that commitment was raised to $300 million annually, and the fund has $2 billion under management. In 2014, the group announced $125 million to invest in promising European startups.
GV has offices in Mountain View, San Francisco, New York City, Cambridge, and London.